APLM vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

APLM

65.8
AI Score
VS
APLM Wins

ICU

56.7
AI Score

Investment Advisor Scores

APLM

66score
Recommendation
STRONG BUY

ICU

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric APLM ICU Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 380.8% 82.0% APLM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 65.8/100 56.7/100 APLM
Profit Margin -123.7% 0.0% ICU
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD APLM

Relative Price Performance (Last 90 Days)

APLM 1M: -19.5% · 3M: +0.1% ICU 1M: -65.1% · 3M: -67.0%

Current Technical Phase

APLM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.9 · Price: $17.30

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 23

RSI (14): 22.7 · Price: $1.05

Fundamentals Snapshot

Metric APLM ICU
Market Cap — —
Forward P/E 0.0 -0.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 3.8% 0.8%
Gross Margin 1.0% 0.9%
Operating Margin 4.3% -8.2%
EPS -7.57 -2.97
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, APLM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.